The "Adjuvants Market Analysis - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
'Adjuvant' is derived from the Latin, word 'adjuvare' which translated to English means 'to help'. Adjuvants are hence designed to helping to improve poorly immunogenic vaccines.
Adjuvants were originally described as substances which when used in combination with a specific antigen that produce a more robust immune response than the antigen alone, thus encompassing a wide range of materials. Vaccines efficacy has been reduced significantly due to the demand for the vaccines that are less reactive and safer for intake and at the same time also capable of inducing cell-mediated immunity hence there have been significant developments to produce such products for plants, animals as well as in human vaccines.
Adjuvants can be categorized into two broad groups; the particulate vaccine-delivery systems and the immune stimulatory adjuvants on the basis of their action mechanism which is not yet determined clearly due to complex course of action but still based on generalized results research has continued and results also achieved. .
Adjuvants are used as additive in all types of medicine i.e. for plants, animals and humans too. In human medicine they are added to the solution for treatment of diseases such as viral, influenza, etc. Inflammation, tissue destruction, and the potential for resulting pain and distress in the host animal arises due to immunostimulatory properties of adjuvants. Adjuvants that are used for experimental purposes are used to produce antibodies for use in other experimental or diagnostic procedures. Emulsions are the most commonly used depot agents in the experimental production of polyclonal antibodies.
Emulsions may be water-in-oil emulsions, oil-in-water emulsions, or more complex types such as water-oil-water emulsions. In addition to carrying and protecting the antigen from proteolytic destruction, an adjuvant should preserve the conformational integrity of an antigen and present the antigen to the appropriate effector cells, usually professional antigen-presenting cells and macrophages. Immunomodulators and immunostimulators are used in many adjuvants to recruit, activate, and enhance differentiation of the cells of the immune system.
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
Key Topics Covered:
1. Adjuvants - Market Overview
2. Executive Summary
3. Adjuvants - Market Landscape
4. Adjuvants - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Adjuvants Industry
5. Adjuvants Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Suppliers/Distributors Analysis
6. Adjuvants Market - By Application:
6.1. Agrochemicals (Insecticides, Fungicides, Herbicides, and Fertilizers),
6.3. Pharmaceuticals and
7. Adjuvants Market - By Geography:
7.2. North America
8. Market Entropy
8.1. New Product Launches
8.2. M&As, Collaborations, JVs and Partnerships
9. Company Profiles
9.1. AkzoNobel N.V.,
9.2. Croda International PLC,
9.3. Evonik Industies AG,
9.4. Huntsman Corporation,
9.5. Solvay SA,
9.6. Helena Chemical Company,
9.7. Novavax, Inc.,
9.8. Adjuvant Partners, LLC and
9.9. OZ Biosciences Inc.
For more information about this report visit https://www.researchandmarkets.com/r/le0er4
View source version on businesswire.com: https://www.businesswire.com/news/home/20201020005661/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900